The Food and Drug Administration plans to revoke approval of Avastin, a popular drug used to treat metastatic breast cancer. Avastin earned drug maker Hoffman-La Roche nearly $6 billion in 2009, making it a top-seller for the Swiss pharmeceutical company. The FDA gave it the green light in 2008, based on studies indicating that it slowed the spread of breast cancer for more than five months. [...more]
Share The United States Food and Drug Administration may be gaming with the impression of getting the very uncommon step of withdrawing endorsement of a medicine that patients with higher breast cancer revolve to as a final expectation. This medicine, Avastin, has been recommended to around 17,500 women experiencing from breast cancer yearly. The medicine [...] [...more]
Share Bitter melon, a vegetable commonly eaten in China and India is said to be effective in regulating and neutralizing the blood sugar and even cholesterol levels. Saint Louis University proved through their studies that the vegetable is able to generate a series of events on a cellular level that prevents and stops breast cancer [...] [...more]
Share Prevention is better than cure, so as breast cancer is now getting more vicious, women should be able to stop and prevent this rather than just fight it when it hits them. Studies claim that the best way to prevent breast cancer is to eat, but not just any food. Here are the foods [...] [...more]
|
|
